{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T04:01:09Z","timestamp":1784779269323,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Guangdong Basic and Applied Basic Research Foundation of China","award":["2024A1515013288"],"award-info":[{"award-number":["2024A1515013288"]}]},{"name":"Guangdong Basic and Applied Basic Research Foundation of China","award":["2020A1515010224"],"award-info":[{"award-number":["2020A1515010224"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00210-026-05388-5","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T02:11:39Z","timestamp":1777255899000},"page":"15351-15362","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dehydrocostus lactone attenuates hepatic steatosis by regulating fatty acid oxidation and lipid metabolism: integrated transcriptomic and metabolomic analysis"],"prefix":"10.1007","volume":"399","author":[{"given":"Xiaojia","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haolin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahai","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weitao","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gengji","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhizhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"5388_CR1","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.pharmthera.2019.01.006","volume":"197","author":"WS Blaner","year":"2019","unstructured":"Blaner WS (2019) Vitamin A signaling and homeostasis in obesity, diabetes, and metabolic disorders. Pharmacol Ther 197:153\u2013178","journal-title":"Pharmacol Ther"},{"key":"5388_CR2","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen S, Zhou Y, Chen Y, Gu J (2018) fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34:i884\u2013i890","journal-title":"Bioinformatics"},{"key":"5388_CR3","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/j.jhep.2023.08.023","volume":"79","author":"X Chen","year":"2023","unstructured":"Chen X, Chen S, Pang J, Huang R, You Y, Zhang H, Xiao J, Xue H, Ling W (2023) Hepatic steatosis aggravates atherosclerosis via small extracellular vesicle-mediated inhibition of cellular cholesterol efflux. J Hepatol 79:1491\u20131501","journal-title":"J Hepatol"},{"key":"5388_CR4","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jare.2024.01.028","volume":"67","author":"Y Chen","year":"2025","unstructured":"Chen Y, Shen J, Yuan M, Li H, Li Y, Zheng S, Han B, Zhang C, Liu S, Sun Q, Wu J (2025) Dehydrocostus lactone suppresses gastric cancer progression by targeting ACLY to inhibit fatty acid synthesis and autophagic flux. J Adv Res 67:331\u2013348","journal-title":"J Adv Res"},{"key":"5388_CR5","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1124\/pharmrev.121.000408","volume":"74","author":"M Dambrova","year":"2022","unstructured":"Dambrova M, Makrecka-Kuka M, Kuka J, Vilskersts R, Nordberg D, Attwood MM, Smesny S, Sen ZD, Guo AC, Oler E, Tian S, Zheng J, Wishart DS, Liepinsh E, Schi\u00f6th HB (2022) Acylcarnitines: nomenclature, biomarkers, therapeutic potential, drug targets, and clinical trials. Pharmacol Rev 74:506\u2013551","journal-title":"Pharmacol Rev"},{"key":"5388_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232213933","author":"IMS Guerra","year":"2022","unstructured":"Guerra IMS, Ferreira HB, Melo T, Rocha H, Moreira S, Diogo L, Domingues MR, Moreira ASP (2022) Mitochondrial fatty acid \u03b2-oxidation disorders: from disease to lipidomic studies-a critical review. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms232213933","journal-title":"Int J Mol Sci"},{"key":"5388_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacbts.2025.05.004","volume":"10","author":"A Hakeem","year":"2025","unstructured":"Hakeem A, van Berlo J, Revelo XS (2025) The cardiohepatic axis in metabolic disease: liver to heart. JACC Basic Transl Sci 10:101309","journal-title":"JACC Basic Transl Sci"},{"key":"5388_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adj8192","volume":"17","author":"D Henry","year":"2025","unstructured":"Henry D, Baug\u00e9 E, Hennuyer N, Ory K, Derudas B, Vallez E, Deprince A, Lefebvre P, Haas JT, Staels B, Lalloyer F (2025) Anti-inflammatory, but not lipid-lowering, activity of hepatocyte PPAR\u03b1 improves atherosclerosis in Ldlr-deficient mice. Sci Transl Med 17:eadj8192","journal-title":"Sci Transl Med"},{"key":"5388_CR9","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s10020-025-01265-8","volume":"31","author":"W Hong","year":"2025","unstructured":"Hong W, Chen X, Xiao J, Chen G, Yang J, Zhang P, Zhang Z (2025) Dehydrocostus lactone attenuates atherogenesis by promoting cholesterol efflux and inhibiting inflammation via TLR2\/PPAR-\u03b3\/NF-\u03baB signaling pathway. Mol Med 31:243","journal-title":"Mol Med"},{"key":"5388_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.106075","volume":"78","author":"SY Kim","year":"2020","unstructured":"Kim SY, Heo S, Kim SH, Kwon M, Sung NJ, Ryu AR, Lee MY, Park SA, Youn HS (2020) Suppressive effects of dehydrocostus lactone on the toll-like receptor signaling pathways. Int Immunopharmacol 78:106075","journal-title":"Int Immunopharmacol"},{"key":"5388_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2021.101109","volume":"83","author":"H Li","year":"2021","unstructured":"Li H, Yu XH, Ou X, Ouyang XP, Tang CK (2021) Hepatic cholesterol transport and its role in non-alcoholic fatty liver disease and atherosclerosis. Prog Lipid Res 83:101109","journal-title":"Prog Lipid Res"},{"key":"5388_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70367","volume":"6","author":"Q Lv","year":"2025","unstructured":"Lv Q, Zhang Y, Wang J, Lin W, Xie Y, Yang H, Yin X, Zhu Z, Cui Y, Hu Y, Zeng L, Zhang Y, Chen X, Liu J, Hu L (2025) Dehydrocostus lactone effectively alleviates inflammatory diseases by covalently and irreversibly targeting NLRP3. MedComm (2020) 6:e70367","journal-title":"MedComm (2020)"},{"key":"5388_CR13","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1194\/jlr.D700041-JLR200","volume":"49","author":"V Matyash","year":"2008","unstructured":"Matyash V, Liebisch G, Kurzchalia TV, Shevchenko A, Schwudke D (2008) Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J Lipid Res 49:1137\u20131146","journal-title":"J Lipid Res"},{"key":"5388_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153588","volume":"87","author":"F Meng","year":"2021","unstructured":"Meng F, Zong W, Wei X, Tao Y, Wang G, Liao Z, Chen M (2021) Dolomiaea souliei ethyl acetate extract protected against \u03b1-naphthylisothiocyanate-induced acute intrahepatic cholestasis through regulation of farnesoid x receptor-mediated bile acid metabolism. Phytomedicine 87:153588","journal-title":"Phytomedicine"},{"key":"5388_CR15","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/s41569-021-00569-6","volume":"18","author":"D Montaigne","year":"2021","unstructured":"Montaigne D, Butruille L, Staels B (2021) PPAR control of metabolism and cardiovascular functions. Nat Rev Cardiol 18:809\u2013823","journal-title":"Nat Rev Cardiol"},{"key":"5388_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.pharmthera.2017.01.004","volume":"173","author":"JL Napoli","year":"2017","unstructured":"Napoli JL (2017) Cellular retinoid binding-proteins, CRBP, CRABP, FABP5: effects on retinoid metabolism, function and related diseases. Pharmacol Ther 173:19\u201333","journal-title":"Pharmacol Ther"},{"key":"5388_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106786","volume":"192","author":"YY Qiu","year":"2023","unstructured":"Qiu YY, Zhang J, Zeng FY, Zhu YZ (2023) Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD). Pharmacol Res 192:106786","journal-title":"Pharmacol Res"},{"key":"5388_CR18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.tem.2023.10.002","volume":"35","author":"PMM Ruppert","year":"2024","unstructured":"Ruppert PMM, Kersten S (2024) Mechanisms of hepatic fatty acid oxidation and ketogenesis during fasting. Trends Endocrinol Metab 35:107\u2013124","journal-title":"Trends Endocrinol Metab"},{"key":"5388_CR19","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jcmgh.2020.07.006","volume":"11","author":"A Saeed","year":"2021","unstructured":"Saeed A, Bartuzi P, Heegsma J, Dekker D, Kloosterhuis N, de Bruin A, Jonker JW, van de Sluis B, Faber KN (2021) Impaired hepatic Vitamin A metabolism in NAFLD mice leading to Vitamin A accumulation in hepatocytes. Cell Mol Gastroenterol Hepatol 11:309-325.e303","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"5388_CR20","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1261\/rna.053959.115","volume":"22","author":"NJ Schurch","year":"2016","unstructured":"Schurch NJ, Schofield P, Gierli\u0144ski M, Cole C, Sherstnev A, Singh V, Wrobel N, Gharbi K, Simpson GG, Owen-Hughes T, Blaxter M, Barton GJ (2016) How many biological replicates are needed in an RNA-seq experiment and which differential expression tool should you use? RNA 22:839\u2013851","journal-title":"RNA"},{"key":"5388_CR21","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.7150\/ijbs.105361","volume":"21","author":"K Smolkov\u00e1","year":"2025","unstructured":"Smolkov\u00e1 K, Gotvaldov\u00e1 K (2025) Fatty acid trafficking between lipid droplets and mitochondria: an emerging perspective. Int J Biol Sci 21:1863\u20131873","journal-title":"Int J Biol Sci"},{"key":"5388_CR22","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.tem.2019.08.008","volume":"30","author":"D Stols-Gon\u00e7alves","year":"2019","unstructured":"Stols-Gon\u00e7alves D, Hovingh GK, Nieuwdorp M, Holleboom AG (2019) NAFLD and atherosclerosis: two sides of the same dysmetabolic coin? Trends Endocrinol Metab 30:891\u2013902","journal-title":"Trends Endocrinol Metab"},{"key":"5388_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2021.101117","volume":"84","author":"M Sz\u00e1nt\u00f3","year":"2021","unstructured":"Sz\u00e1nt\u00f3 M, Gupte R, Kraus WL, Pacher P, Bai P (2021) PARPs in lipid metabolism and related diseases. Prog Lipid Res 84:101117","journal-title":"Prog Lipid Res"},{"key":"5388_CR24","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.jhep.2018.01.023","volume":"68","author":"LB VanWagner","year":"2018","unstructured":"VanWagner LB (2018) New insights into NAFLD and subclinical coronary atherosclerosis. J Hepatol 68:890\u2013892","journal-title":"J Hepatol"},{"key":"5388_CR25","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1124\/pr.118.017178","volume":"71","author":"D Wang","year":"2019","unstructured":"Wang D, Yang Y, Lei Y, Tzvetkov NT, Liu X, Yeung AWK, Xu S, Atanasov AG (2019) Targeting foam cell formation in atherosclerosis: therapeutic potential of natural products. Pharmacol Rev 71:596\u2013670","journal-title":"Pharmacol Rev"},{"key":"5388_CR26","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1142\/S0192415X19500666","volume":"47","author":"JH Woo","year":"2019","unstructured":"Woo JH, Ahn JH, Jang DS, Choi JH (2019) Effect of Dehydrocostus lactone isolated from the roots of Aucklandia lappa on the apoptosis of endometriotic cells and the alternative activation of endometriosis-associated macrophages. Am J Chin Med 47:1289\u20131305","journal-title":"Am J Chin Med"},{"key":"5388_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22189754","author":"YX Wu","year":"2021","unstructured":"Wu YX, Jiang FJ, Liu G, Wang YY, Gao ZQ, Jin SH, Nie YJ, Chen D, Chen JL, Pang QF (2021) Dehydrocostus Lactone attenuates Methicillin-Resistant Staphylococcus aureus-induced inflammation and acute lung injury via modulating macrophage polarization. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22189754","journal-title":"Int J Mol Sci"},{"key":"5388_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107780","volume":"98","author":"Y Xiong","year":"2021","unstructured":"Xiong Y, Cui X, Zhou Y, Chai G, Jiang X, Ge G, Wang Y, Sun H, Che H, Nie Y, Zhao P (2021) Dehydrocostus lactone inhibits BLM-induced pulmonary fibrosis and inflammation in mice via the JNK and p38 MAPK-mediated NF-\u03baB signaling pathways. Int Immunopharmacol 98:107780","journal-title":"Int Immunopharmacol"},{"key":"5388_CR29","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.jhep.2024.09.029","volume":"82","author":"X Yang","year":"2025","unstructured":"Yang X, Deng B, Zhao W, Guo Y, Wan Y, Wu Z, Su S, Gu J, Hu X, Feng W, Hu C, Li J, Xu Y, Huang X, Lin Y (2025) FABP5(+) lipid-loaded macrophages process tumour-derived unsaturated fatty acid signal to suppress T-cell antitumour immunity. J Hepatol 82:676\u2013689","journal-title":"J Hepatol"},{"key":"5388_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202415846","volume":"12","author":"YY Yu","year":"2025","unstructured":"Yu YY, Feng M, Chen Y, Jia HL, Zhang Q, Tong M, Li YX, Zhao Y, Liu XX, Cao SF, Wang ZK, Li HW, Liu X, Zhang Y (2025) Asprosin-FABP5 interaction modulates mitochondrial fatty acid oxidation through PPAR\u03b1 contributing to MASLD development. Adv Sci (Weinh) 12:e2415846","journal-title":"Adv Sci (Weinh)"},{"key":"5388_CR31","doi-asserted-by":"publisher","first-page":"3428","DOI":"10.1021\/acs.orglett.0c00898","volume":"22","author":"SS Zhu","year":"2020","unstructured":"Zhu SS, Liu JW, Yan YM, Liu Y, Mao Z, Cheng YX (2020) Terpenoids from Resina Commiphora regulating lipid metabolism via activating","journal-title":"Org Lett"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05388-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05388-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05388-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T03:03:59Z","timestamp":1784775839000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05388-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["5388"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05388-5","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"24 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Animal Care and Use Committee of Guangdong Medical University approved this study protocol (Approval Number: GDY2004026) and conducted in strict accordance with ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines 2.0 and Chinese National Standards for Laboratory Animal Welfare (GB\/T 35892\u20132018).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}]}}